Articles by James Calloway
XP Inc. Stock Slides on Q1 Results: Weaker Inflows and Retail Take Rate Dampen Buyback Enthusiasm
XP Inc. shares dropped 3.78% in after-hours trading Monday after Q1 earnings showed higher profit but weaker net inflows and a lower retail take rate, offsetting a new buyback program.
Agilysys Stock Surges on Record Revenue and Strong Fiscal 2027 Forecast
Agilysys shares surged 16.7% in after-hours trading following record fiscal Q4 revenue and a fiscal 2027 outlook that exceeded current sales, bucking a weaker tech market.
NextNRG Stock Surges on Revenue Growth, but Liquidity Concerns Loom
NextNRG stock jumped 44% on strong Q1 revenue, but a net loss and going concern warning highlight ongoing liquidity challenges.
Wellgistics Health Surges 108% on Strategic Review, Earnings Ahead
Wellgistics Health shares skyrocketed 108% on Monday after the company withdrew proxy materials to explore strategic transactions, with first-quarter earnings due Tuesday.
Figma Stock Tests Recovery as AI Monetization Gains Traction
Figma shares edged higher Monday after the company reported a 46% revenue surge and raised its 2026 forecast, buoyed by early traction in AI credit monetization.
Nvidia Shares Dip Ahead of Earnings as Wall Street Watches for AI Demand Signals
Nvidia shares dropped 2.8% Monday ahead of its fiscal first-quarter earnings, as profit-taking and rising Treasury yields weighed on chip stocks. Analysts project $78.5 billion in revenue, with data center sales key.
Nu Holdings' Record Revenue Overlooked as Loan Provisions Rise
Nu Holdings shares fell 0.1% Monday as investors focused on higher loan-loss provisions, overshadowing record Q1 revenue of $5.3 billion and net income of $871 million.
SoFi shares flat after record Q1, tech platform revenue drops 27%
SoFi shares were flat Monday after record Q1 results, with net revenue up 43% to $1.10B but technology platform revenue down 27%.
Costco Shares Surge Amid Consumer Caution; Valuation Stays Elevated
Costco shares climbed to $1,064.98 as April sales rose 13% to $23.92B. The company raised its dividend and will report fiscal Q3 earnings on May 28.
Apellis Delisted After Biogen Buyout; CVR Payout in Focus
Apellis Pharmaceuticals has been delisted from Nasdaq following Biogen's completed acquisition. Shareholders get $41 per share plus a contingent value right worth up to $4 if Syfovre meets sales goals.
Analysts Boost Walmart Targets Ahead of Q1 Earnings Report
Walmart shares gained 0.8% Monday after multiple Wall Street analysts raised price targets ahead of the retailer's fiscal first-quarter earnings report on Thursday.